Ventilation With ASV Mode in Children
Monocentric Interventional Study on the Feasibility of the Invasive Mechanical Ventilation Mode "Adaptive Support Ventilation, ASV" in a Pediatric Population and Comparison to Pressure-Control and Pressure-Support Ventilation Modes
1 other identifier
interventional
40
1 country
1
Brief Summary
ASV mode of ventilation is an automatic mode with closed-loop control used for mechanical invasive ventilation in intubated patients. It has been studied in adult patients but not in children. This interventional physiology study will include 40 children on mechanical invasive ventilation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2019
CompletedFirst Posted
Study publicly available on registry
April 29, 2019
CompletedStudy Start
First participant enrolled
September 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2023
CompletedDecember 13, 2023
December 1, 2023
4.2 years
April 12, 2019
December 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change of respiratory rate
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Change of tidal volume
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Change of peak inspiratory pressure
Physiological respiratory value of mechanical ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Secondary Outcomes (20)
Evolution of Minute Ventilation
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of Mean airway pressure
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of inspiratory time
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of ratio inspiratory time/expiratory time
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
Evolution of Crs (respiratory system compliance calculated by the ventilator)
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
- +15 more secondary outcomes
Study Arms (4)
Passive phase, Pressure-Control Ventilation / ASV order
EXPERIMENTAL90 minutes of Pressure-Control Ventilation, change to ASV mode with 15 to 30 minutes of washout, 90 minutes of ASV. Return to Pressure-Control Ventilation mode at the end of the intervention.
Passive phase, ASV / Pressure-Control Ventilation order
EXPERIMENTAL90 minutes of ASV, change to Pressure-Control Ventilation mode with 15 to 30 minutes of washout, 90 minutes of Pressure-Control Ventilation.
Active phase, Pressure-Support / ASV order
EXPERIMENTAL90 minutes of Pressure-Support Ventilation, change to ASV mode with 15 to 30 minutes of washout, 90 minutes of ASV. Return to Pressure-Support Ventilation at the end of the intervention.
Active phase, ASV / Pressure-Support order
EXPERIMENTAL90 minutes of ASV, change to Pressure-Support Ventilation with 15 to 30 minutes of washout, 90 minutes of Pressure-Support Ventilation.
Interventions
Ventilation on ASV mode
Eligibility Criteria
You may qualify if:
- children on invasive mechanical ventilation admitted in the Pediatric Intensive Care Unit at Lausanne University Hospital
- Body weight \> 6kg
- Absence of pulmonary comorbidity
- Age \< 10 years
You may not qualify if:
- Patient already included in other interventional clinical study
- body weight \< 6kg
- age \> 10 years
- more than 20% of air leak around endotracheal tube
- chronic or acute pulmonary disease (ARDS, cystic fibrosis, severe asthma, lobectomy, severe bronchomalacia or severe tracheomalacia)
- severe pulmonary hypertension on inhaled nitric oxide treatment
- severe hemodynamic instability (more than 0.5mcg/kg/min of norepinephrine infusion or other high dose vasoactive agent infusion)
- intracranial hypertension (more than 20mmHg if measured) or suspected intracranial hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lausanne University Hospital
Lausanne, 1011, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Ferry, MD
University of Lausanne Hospitals
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 12, 2019
First Posted
April 29, 2019
Study Start
September 13, 2019
Primary Completion
December 5, 2023
Study Completion
December 5, 2023
Last Updated
December 13, 2023
Record last verified: 2023-12